FDA approves Symproic (naldemedine) once-daily tablets C-II for the treatment of Opioid-Induced Constipation in Adults with chronic non-cancer pain
23 Mar 2017
24.03.2017 FDA Approves Symproic_naldemedine
Shionogi Limited. Registered in England and Wales No. 07945432. Registered office: 33 Kingsway. London WC2B 6UF, UK.
Report Side Effect
Just to let you know, you are now moving to another website this is not under our control and Shionogi Limited is not responsible for its contents.